Mark Dybul - 25 Aug 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Chief Executive Officer, Director
Signature
/s/ Mark R. Dybul
Issuer symbol
RENB
Transactions as of
25 Aug 2022
Net transactions value
$0
Form type
4
Filing time
15 Sep 2022, 12:36:16 UTC
Previous filing
22 Jul 2021
Next filing
16 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to purchase shares of common stock Award $0 +350,000 $0.000000 350,000 25 Aug 2022 Common stock 350,000 $2.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on August 25, 2023, August 25, 2024 and August 25, 2025.